home > epc

European Pharmaceutical Contractor


Published quarterly, European Pharmaceutical Contractor (EPC) covers the essential contract research issues between pharma companies and their CRO partners. The title, which is integrated within International Clinical Trials (ICT) magazine, offers a strategic view of the drug development industry – giving its pharma, biotech and CRO readership expert insight and analysis on the sponsor-service provider landscape.

EPC focuses on key trends, concerns and developments in contract research operations across the drug development spectrum, from preclinical to post-marketing. It explores the shifting collaborative needs and practical implications for sponsors and their contract partners, with the emphasis on building and managing effective collaborations.

Prompted by the synergies between outsourcing and trial operations, EPC joined forces with sister brand ICT in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.


For further information please contact:

Nick Matthews

Thanh Thanh Lam

We're also on Twitter! Follow us @EPCmagazine

The latest digital edition of EPC can be viewed here

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

Featured in this issue
Data Management & IT Solutions

SAS and R Team in Clinical Research

To either prove or disprove stated hypotheses, it is necessary to carry out statistical analyses and collect data. KCR’s Adrian Olszewski introduces two reliable packages to support evidencebased research on drugs.

Legal & Regulatory

The Path to Easier Product Lifecycle Maintenance

TRAC Services
reveals the importance of the regulatory affairs function within pharma, and how good document management is critical in the successful production of drugs.
  Legal & Regulatory
Data De-Identification

Protecting Patient Identities

As organisations are required to become more transparent in their studies, the identities of patients are being put at risk. d-Wise’s Chris Olinger comments on new guidelines trying to alleviate this problem.


Published quarterly in
February, May,
August and November


Industry Events

BIO-Europe 2016

7-9 November 2016, KoelnMesse Congress Center North

The 22nd annual BIOEurope event is the largest biotechnology partnering conference held in Europe. Over 3,500 global decision makers from biotechnology, pharma and finance annually attend BIOEurope to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIOEurope a mustattend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIOEurope features the industry’s most advanced webbased partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
More info >>

News and Press Releases

Envigo collaboration with OCSiAl and Intertek results in single wall carbon nanotubes completing REACH registration for the first time ever

Envigo is pleased to announce the successful outcome of its industry collaboration with Intertek and OCSiAl to meet the latter's regulatory requirements for its core product: TUBALL™ single wall carbon nanotubes. As a result of the collaboration, OCSiAl has opened a new substance in the EU's Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation under the number 01-2120130006-75-0000.
More info >>

air transport logo


White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement